Edible oil and food products major Ruchi Soya Industries, which will launch its Rs 4,300-crore follow-on public offer in the next few days, intends to reduce its edible oil imports in 5 to 7 years
CISF is providing security to 64 airports and 11 private establishments, including those of Reliance Industries, Tata Steel and Infosys, Union Minister of State for Home Nityanand Rai said
Group aims to make its companies debt-free in 3-4 yrs
In a shot in the arm for yoga guru Ramdev-run Patanjali group, the Income Tax Department has extended tax deductions on donations made to Patanjali Research Foundation Trust for five years.
Patanjali Group said it has achieved a turnover of around Rs 30,000 crore in the fiscal 2020-21
While Colgate has the Vedshakti brand in the naturals segment, experts say the product has not helped stem market share loss for the oral care major
On Sunday, Ramdev was forced to withdraw a statement made in a viral video clip in which he is heard questioning some of the medicines being used to treat the coronavirus infection
Ruchi Soya Industries on Tuesday announced the acquisition of biscuits business from Patanjali Natural Biscuits Pvt Ltd (PNBPL) in a slump sale at Rs 60.02 crore.
The Delhi Medical Association on Tuesday took exception to the critical statement issued by the IMA on the launch of Patanjali's Coronil tablet in the presence of Union minister Harsh Vardhan
The sale of Coronil tablets of Patanjali will not be allowed in Maharashtra without "proper certification", state Home Minister Anil Deshmukh said on Tuesday. The statement came a day after the Indian Medical Association (IMA) expressed shock over the "blatant lie of WHO certification" for Coronil tablets which Patanjali claims is an evidence-based medicine to fight COVID-19. While the IMA also demanded an explanation from Union Health Minister Harsh Vardhan in whose presence the medicine was launched, the World Health Organization clarified that it had not reviewed or certified the effectiveness of any traditional medicine for the treatment of COVID-19. Without naming anyone, Deshmukh said on Twitter that it was "highly deplorable" that two senior Union ministers endorsed the drug. "The #IMA has questioned the said 'clinical trials' of #Coronil & WHO refuted the false claims made by #Patanjali Ayurveda for giving any certificate regarding its effectiveness for ...
The launch was attended by Union Health Minister Harsh Vardhan and Transport Minister Nitin Gadkari.
Patanjali MD Acharya Balkrishna said that Coronil has been granted a certificate of pharmaceutical product, licensed by DCGI
Ramdev-led Patanjali Ayurved had launched 'Coronil', for treating Covid-19 on June 23
CSE's report on honey points to the need for better standards
Patanjali acquired Ruchi Soya, which is listed on stock exchanges, through an insolvency process last year
While the company's operating revenue grew 6%, net profit jumped 22% in FY2020
From oxygen supply shortage hitting industries to Coronil kits' popularity, here's a roundup of articles on how the country is dealing with the pandemic
50 petitions pending in court, court asks each petitioner to submit its arguments within five pages
Sebi proposal follows surge in Ruchi Soya stockprice; higher disclosure norms on the cards
Borrowing costs on bonds have plunged after policy makers unveiled record stimulus to help combat the financial fallout of the pandemic